Hypothesis

1 Matching Annotations

Jun 2016
clinicaltrials.gov clinicaltrials.gov

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC). - Full Text View - ClinicalTrials.gov

1
1. kerfors 01 Jun 2016
  
  in Public
  
  Test of annotating a clinical trial registry entry
  
  StudyAnnotation
Visit annotations in context

Tags

StudyAnnotation

Annotators

kerfors

URL

clinicaltrials.gov/ct2/show/NCT02453282